Pharmacist recommendations to improve the quality of diabetes care: A randomized controlled trial

Journal of Managed Care Pharmacy

Volumn 16, Issue 2, 2010, Pages 104-113

  Kirwin, Jennifer L ^a   Cunningham, Rebecca J ^b,c   Sequist, Thomas D ^b,c  

^a NORTHEASTERN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BIOLOGICAL MARKER; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PNEUMOCOCCUS VACCINE;

ARTICLE; CLINICAL PRACTICE; DECISION MAKING; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; FOLLOW UP; HEALTH CARE QUALITY; HOSPITAL CARE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MEDICAL RECORD REVIEW; MEDICAL RESEARCH; MICROALBUMINURIA; OUTCOME ASSESSMENT; PHARMACIST; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PREDICTION; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; QUALITY CONTROL;

EID: 77950833834     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2010.16.2.104     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2008. Available at: http://www.cdc.gov/diabetes/ pubs/pdf/ndfs-2007pdf. Accessed February 5, 2010.
2. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003;26(Suppl 1): S33-S50.
3. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-53.
4. Snow V, Weiss KB, Mottur-Pilson C. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Ann Intern Med. 2003;138(7):587-92. Available at: http://www.annals.org/content/138/7/587. fullpdf+html. Accessed February 5, 2010.
5. Vijan S, Hayward RA. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med. 2003;138(7):593-602. Available at: http://www.annals.org/content/138/7/593.fullpdf+html. Accessed February 5, 2010.
6. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861-69. Available at: http://content.nejm.org/cgi/ reprint/345/12/861pdf. Accessed February 5, 2010.
7. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851-60. Available at: http://content.nejm.org/cgi/content/full/345/12/851. Accessed February 5, 2010.
8. National Committee for Quality Assurance. The State of Health Care Quality 2009. NCQA. Washington DC, 2009. Available at http://www.ncqa org/Portals/0/Newsroom/SOHC/SOHC-2009pdf. Accessed February 5, 2010.
9. Lobach DF, Hammond WE. Computerized decision support based on a clinical practice guideline improves compliance with care standards. Am J Med. 1997;102(1):89-98.
10. Sequist TD, Gandhi TK, Karson AS, et al. A randomized trial of electronic clinical reminders to improve quality of care for diabetes and coronary artery disease. J Am Med Inform Assoc. 2005;12(4):431-37. Available at: http://jamia.bmj.com/content/12/4/431.full. Accessed February 5, 2010.
11. Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes in glycemic control: a meta-regression analysis. JAMA. 2006;296(4):427-40. Available at: http://jama.ama-assn.org/cgi/content/ full/296/4/427. Accessed February 5, 2010.
12. Litzelman DK, Dittus RS, Miller ME, Tierney WM. Requiring physicians to respond to computerized reminders improves their compliance with preventive care protocols. J Gen Intern Med. 1993;8(6):311-17.
13. Bates DW, Kuperman GJ, Wang S, et al. Ten commandments for effective clinical decision support. J Am Med Inform Assoc. 2003;10(6):523-30.
14. Wubben DP, Vivian EM. Effects of pharmacist outpatient intervention on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421-36.
15. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and metaanalysis in diabetes management. Ann Pharmacother. 2007;41(10):1569-82.
16. Doucette WR, Witry MJ, Farris KB, McDonough RP. Community pharmacist-provided extended diabetes care. Ann Pharmacother. 2009;43(5):882-89.
17. Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension therapy management program in patients with diabetes. J Am Pharm Assoc. 2009;49(2):164-70.
18. McLean DL, McAlister FA, Johnson JA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: a study of cardiovascular risk intervention by pharmacists-hypertension (SCRP-HTN). Arch Intern Med. 2008;168(21):2355-61. Available at: http://archinte.ama-assn.org/cgi/reprint/ 168/21/2355. Accessed February 5, 2010.
19. National Committee for Quality Assurance. HED1S and Quality Measurement. http://www.ncqa.org/tabid/59/Default.aspx. Accessed on February 5, 2010.
20. Sequist TD, Adams A, Zhang F, Ross-Degnan D, Ayanian JZ. Effect of quality improvement on racial disparities in diabetes care. Arch Intern Med. 2006;166(6):675-81. Available at: http://archinte.ama-assn.org/cgi/reprint/166/ 6/675. Accessed February 5, 2010.
21. Altavela JL, Jones MK, Ritter M. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system. J Manag Care Pharm. 2008;14(9) 831-43. Available at: http://www.amcp.org/data/ jmcp/831-843pdf.
22. McFarland MS, Cross LB, Gross B, Gentry C, Tunney J, Patel UP. Drug use evaluation of sitagliptin dosing by pharmacist versus nonpharmacist clinicians in an internal medicine department of a private physician-owned multispecialty clinic. J Manag Care Pharm. 2009;15(7) 563-67. Available at: http://www.amcp.org/data/jmcp/563-567pdf.